相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The Value of New Chemotherapeutic Agents for Metastatic Colorectal Cancer
David H. Howard et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
The Value of Specialty Oncology Drugs
Dana P. Goldman et al.
HEALTH SERVICES RESEARCH (2010)
Why Do the Elderly Save? The Role of Medical Expenses
Mariacristina De Nardi et al.
JOURNAL OF POLITICAL ECONOMY (2010)
Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy
Scott Kopetz et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Public health services and cost-effectiveness analysis
H. David Banta et al.
ANNUAL REVIEW OF PUBLIC HEALTH (2008)
Saying No Isn't Nice - The Travails of Britain's National Institute for Health and Clinical Excellence
Robert Steinbrook
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Adjusting the value of a statistical life for age and cohort effects
Joseph E. Aldy et al.
REVIEW OF ECONOMICS AND STATISTICS (2008)
The cost-effectiveness of bevacizumab in the first-line treatment of metastatic colorectal cancer in England and Wales
P. Tappenden et al.
EUROPEAN JOURNAL OF CANCER (2007)
Prescription drug cost sharing associations with medication and medical utilization and spending and health
Dana P. Goldman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Cost-effectiveness analysis of cetuximab/irinotecan vs active/best supportive care for the treatment of metastatic colorectal cancer patients who have failed previous chemotherapy treatment
N. Starling et al.
BRITISH JOURNAL OF CANCER (2007)
The value of health and longevity
Kevin M. Murphy et al.
JOURNAL OF POLITICAL ECONOMY (2006)
Benefit design and specialty drug use
Dana P. Goldman et al.
HEALTH AFFAIRS (2006)
Drug therapy - Systemic therapy for colorectal cancer
JA Meyerhardt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Pharmacy benefits and the use of drugs by the chronically ill
DP Goldman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
The value of a statistical life: A critical review of market estimates throughout the world
WK Viscusi et al.
JOURNAL OF RISK AND UNCERTAINTY (2003)
A meta-analysis of quality-of-life estimates for stroke
TO Tengs et al.
PHARMACOECONOMICS (2003)
Employer drug benefit plans and spending on prescription drugs
GF Joyce et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Willingness to pay for a quality-adjusted life year: In search of a standard
RA Hirth et al.
MEDICAL DECISION MAKING (2000)